Carregant...
Can Propranalol Prevent Hepatocellular Carcinoma?
Beta-adrenergic signaling is involved in many processes that may contribute to cancer progression. In this issue of the journal (beginning on page XX), Nkontchou and colleagues report their retrospective observational finding that the beta-blocker propranolol was associated with a highly statistical...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3415703/ https://ncbi.nlm.nih.gov/pubmed/22869451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-12-0247 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|